Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 10 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Net sales were broadly in line with the forecast. Operating profit was affected by improvements in the cost-of-sales ratio and other factors, ordinary profit by foreign exchange gains and other factors in addition to the factors affecting the difference in operating profit, and net income attributable to owners of the parent by the recognition of an impairment loss of ¥1,243 million at a Chinese subsidiary and other factors.
Impairment loss of ¥1,243 million at a Chinese subsidiary
| Item | Details |
|---|---|
| Net Sales | ¥19,472 million → ¥19,446 million（-0.1%） |
| Operating profit | ¥-180 million → ¥-129 million |
| Ordinary income | ¥-145 million → ¥-85 million |
| Profit attributable to owners of the parent | ¥-214 million → ¥-1,441 million |
| Net income per share | -38.76 yen and sen → -260.93 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 10 February 2026 |
| Previous-period results | Net Sales ¥19,932 million / Operating profit ¥123 million / Ordinary income ¥105 million / Profit attributable to owners of the parent ¥-96 million / Net income per share -17.58 yen and sen |
| Reason for the revision | Net sales were broadly in line with the forecast. Operating profit was affected by improvements in the cost-of-sales ratio and other factors, ordinary profit by foreign exchange gains and other factors in addition to the factors affecting the difference in operating profit, and net income attributable to owners of the parent by the recognition of an impairment loss of ¥1,243 million at a Chinese subsidiary and other factors. |
| Details and amount of extraordinary loss | Impairment loss of ¥1,243 million at a Chinese subsidiary |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales were broadly in line with the forecast. Operating profit exceeded the forecast due to improvements in the cost-of-sales ratio and other factors, while ordinary profit exceeded the forecast due to foreign exchange gains and other factors in addition to the factors affecting the difference in operating profit. Net income attributable to owners of the parent fell below the forecast due to the recognition of an impairment loss of ¥1,243 million at a Chinese subsidiary and other factors.